GSIEF
Share Structure:
Auth. 100M
O/S 99,462,627
Restricted 33,002,167
Float: 12 million m/l No Dilution
gsisecuritization.com
Compushare Trust Co.
Golden, CO
303-262-0889
This is a F stock meaning Foreign… The MM’s don’t print sales. All day you can see the Bid and Ask but not anything else. EOD you can see the high/low Volume and close.
Current chart
www.img505.imageshack.us/img505/8201/gsief032mr5.gif
____________________________________________________
The play
GSIEF will R/M into CMHS a fully reporting OTCBB shell
Ok folks, we now have r/m confirmation with CMHS.
Also confirmation on how the CEO is going to treat the shareholders of GSIEF.
stocrates verified today that 12 million restricted shares have been issued.
I called CEO Slaton, yes, the shares are issued for the merger closing, yes, the shares issued to effect the merger are restricted
THE shell has been purchased with RESTRICTED share = NO dilution
After placement on OTCBB, the company will announce sales of 30 m and profit of 3-4 m for 2007, they are right in line so far with these numbers thru present day.
________________________________________________________________
What is GSI and what do they do….
In a nutshell GSi purchases medical receivables from hospitals pays them a sum for the receivables and does the paper work and such to cash them. Say a hospital has $100 million in receivables Gsi pays the hospital roughly $85 million for them and takes 15%
WHO is involved ..the players…..
_____________________________________________________
Where does GSi get funding
Funding is being provided by The silar group
silaradvisors.com
These are folks that only look at projects that are no less than 100 million
Involved in Goldman sachs /Oppenhiemer
and we believe
Stephen Inc.
stephens.com
BOTH VERY BIG…..
________________________________________________
People involved..
CEO Gunther Slaton.
Chairman; CEO and Founder of GSI Securitization Ltd. is considered an expert in the healthcare finance business in the development of business opportunities for asset-backed high profit, low risk business. He started by working with physician groups in the purchase of hospitals and moved into asset-backed financing instruments setting up a business model experienced in profiling client needs, analysis of data to budgeting and oversight controls of investments to this medical services market covering hospitals, physician groups, specialty hospitals, etal.
He works with all layers of management (1) the financial community meeting prerequisite funding; (2) processing and collection dynamics to secure optimum reimbursement for funds employed in purchasing accounts receivable; (3) security of funds protocol; (4) 24/7 reporting; and (5) operations standards.
His background as an engineer, business financial expertise, know of the healthcare industry, and its shortfalls, which have become opportunities for GSI's emerging growth has propelled GSI's business model into a public company affiliating marketing, sales, operations and reporting aspects of the business. This is management on a collaborative scale for optimum business development, cost effectiveness, and profit for the stockholders.
Beyond healthcare, Mr. Slaton was the general manager of the JELLO Division of General Foods, prior to the purchase by Kraft Foods. In other venues, he worked in the healthcare industry in different capacities in pharmaceuticals and OTC products for consumer consumption. He built, owned and operated a manufacturing and development company in partnership with USM. He graduated from New York's prestigious Stuyvesant in two years; went to the University of Wisconsin on scholarship and received a B.S. Degree in engineering; and then went to Harvard Business School. He received the Gilbreth Award Metal for high achievement in management. Mr. Slaton was born in Germany.
Sally Engel. Vice President Marketing and Sales of GSI Securitization Ltd. is key to business develop, processing and details of management of the business working with all phases of the financial product(s) sales, from inception to contract, and then is involved in reporting and management of oversight of the processes. A complex job covering client relationships, focused sales on individual client needs, proposals, finalizing business deal for contracting done in coordination with Mr. Slaton and all parties involved in the sale, financing and servicing of any business coming into GSI.
In addition, she is responsible for advertising and promotions of GSI and has worked extensively with research, development, demographic, market analysis, design and implementation of graphic and presentations to various targeted markets. In that environment, she is responsible for all individual sales packages with prospective client presentation and specific market product and business offerings. She also works with the public sector with GSI in public relations and stockholder relations.
She has designed, implemented and sold multiple products and services to the healthcare industry and consumer markets expanding profitable market share for Fortune 500 companies, such as FORT DODGE LABORATORIES, AMERICAN HOME PRODUCTS, CARNATION ALBERS, and BLISTEX, etal. She has been involved with GSI from its inception. She attended the University of Kansas majoring in Marketing and Business, Northwestern University business development courses in the Psychology of Marketing through Advertising, Entrepreneurship in Business, and New Trier extension courses in computer technology.
Seymour Spilka, President and CEO, started MediCredit, Inc. in 1990, managing a portfolio of healthcare providers specializing in the no-fault insurance arena financing programs. Mr. Spilka set-up, coordinated, and managed the entire operations of the company in the marketing, sale, net-value determination modeling, financing, processing and collection, accounting and services of the existing and prospective Client base. The asset-backed business has continued to be highly successful and profitable as a niche market specialty business. Mr. Spilka has in excess of 40 years of in-depth experience in the insurance business, financing of receivables insurance no- fault business, processing and collection. President of General Factors Company, started as insurance premium finance company, expanded into commercial financing and leasing. In addition, he was Vice President of Western Plains Mutual Insurance Company handling specialty surplus lines insurance, Penn General Capital Corporation, subsidiary of Pennsylvania Life Insurance Company Vice President, Bankers and Shippers Insurance Company Director, subsidiary of Pennsylvania Life Insurance Company, sold to Travelers Insurance Company.[/U]
Steven J. Phillips, M.D. -- Principal Advisor to the Chairman – Dr. Phillips brings an important dimension to our organization because of his in depth understanding of the transitions emerging in healthcare reimbursement and finance. He has enjoyed a highly successful career as a board certified General and Thoracic Surgery, and well as being a successful business entrepreneur. He established a cardiac surgery program at the University of Oregon to Des Moines, Iowa which today the Iowa Heart Center, a private medical group that has grown to more than 55 physicians and 300 employees, all specializing in cardiovascular disease and a highly profitable business. Dr. Phillips team pioneered techniques for emergency coronary bypass surgery for evolving heart attacks. His concept of acute intervention during a heart attack is presently the universal standard of care. He developed a funded Cardiovascular Research Laboratory at the College of Veterinary Medicine, Iowa State University. During the past 30 years his team implanted the first artificial heart in Iowa, performed the first heart transplant in central Iowa, and invented the technology for percutaneous cardiopulmonary bypass. He has been the principal investigator for numerous research projects. He retired from active medical practice in 2005. In 1997 Dr. Phillips was interviewed by the White House Search Committee for the position of Commissioner of the Food and Drug Administration. On October 7, 1998, he was invited to testify before the Full Committee on Commerce as a witness on the Implementation of the Food and Drug Administration Modernization Act of 1997. He was appointed a member of the Board of Regents of the National Library of Medicine (NLM) of the National Institutes of Health (NIH) and served from 1993-97. He was the 1997 Board Chair. In 1999 he was appointed as the full time Deputy to the Director for Research and Education at the NLM, NIH. In 2002 Dr. Phillips became a founder of and the Chief Medical Officer of Cardiovascular Hospitals of America, LLC. He retired from that position in 2001 but remains an NIH contractor.
Dr. Phillips served twice in Vietnam. He served with the 101st Airborne Division in Vietnam. Stateside he was assigned to the Department of Experimental Surgery at the Walter Reed Army Institute of Research. He returned to Vietnam with a research team to study the effects of altitude on the wounded being flown from Vietnam to the Philippines and Japan .He remained a reserve officer until his retirement as a Lieutenant Colonel. He is a life member of the 101st Airborne Association and an invited Associate Life Member of the UDT/SEAL Association. He has received numerous awards for science and community and charitable service including the International Variety Club Life Time Achievement Award. Dr. Phillips received the Governor of Iowa Science Medal for his scientific efforts and he was the National Science Advisor to the Iowa Department of Health. He presently serves as the North American Editor of the Journal of Artificial Organs, serves or served on numerous editorial, medical society and corporate boards including Dr. Michael E, DeBakey's company, Micromed, Inc., Cobe Laboratories, Inc., and Medical, Cardiovascular, Inc. Dr. Phillips is past president of the Polk County Medical Society, Iowa, past president of the Society of Cardiac Surgeons, Spain; and past president of the American Society for Artificial Internal Organs, USA. He has an active medical license in Iowa and Colorado, has approximately 300 medical publications, and has been granted 6 patents. He is a graduate of Hobart College and Tufts University School of Medicine
Excerpts from PR’s
PRINCETON, N.J., June 21 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF) and MediCredit, Inc. announce today that they have signed a definitive agreement in a Joint Marketing, Sales and Finance Agreement to market, arrange for funding and service ratable healthcare provider receivables for clinical and diagnostic claims for No-Fault/PIP, Workers' Compensation, Medicare, Champus, and company and union sponsored commercial health insurance benefit plans. Management believes that this Agreement will generate additional cash flow of at least $4,000,000. GSI will work with MediCredit clients and new business development to facilitate the sale of asset-backed third-party current, non-current insurance receivables for cash at discounted rates that will cover cost of money, operations, reporting and profit. MediCredit will be responsible for the marketing and sales function, and GSI will provide the asset-backed finance sources. Safety of investment will be managed jointly by accounting and reporting mechanisms already utilized for MediCredit and to GSI's funding group protocol for 24/7 analysis. This value added asset-based business represents an addition phase of business and growth opportunity to GSI to benefit both parties providing capital for clinics, diagnostic testing facilities, laboratories, private and group physician practices, home healthcare agencies, substance abuse clinics, rehabilitation facilities and hospitals. MediCredit, Inc. will continue to establish purchase lines for insurance receivables and GSI will provide funding sources through its partners to for these sales. Reports will provide incisive information for controlling and security of profit centers.The products available will be labeled as 'the Capital Choice' under GSI and MediCredit alliance.
PRINCETON, N.J., June 25 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.PK) announced today that their subsidiary GSI Securitization Inc. have received data for a large specialty hospital group desiring to capitalize their third-party insurance accounts receivable, and are requesting for other funding participation. GSI's expanding market penetration for providing financing to a $12+ billion market starving for cash flow in combination with GSI's exclusivity in only servicing asset-backed medical provider needs is providing the onslaught of new business growth and security of investment which must have a positive impact on earnings.
PRINCETON, N.J., June 26 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk) is pleased to announce today that their subsidiary GSI Securitization Inc. has been notified that it will receive an accounts receivable portfolio for their review and analysis. These receivables are from a very large hospital system representing several millions of dollars. The cost to profit ratios should permit significant growth potential to the company and its shareholders.
PRINCETON, N.J., June 27 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk) announces today that their subsidiary GSI Securitization Inc. will receive an accounts receivable portfolio from a specialty physician group wanting to capitalize their receivables at discount rates to access cash flow for expansion and other business enterprise venues.
PRINCETON, N.J., July 2 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk) has elected stockholder Dr. Steven J. Phillips to its board.
His illustrious background:
Steven J. Phillips, M.D. -- Principal Advisor to the Chairman -- Dr. Phillips brings an important dimension to our organization because of his in depth understanding of the transitions emerging in healthcare reimbursement and finance. He has enjoyed a highly successful career as a board certified General and Thoracic Surgery, and well as being a successful business entrepreneur. He established a cardiac surgery program at the University of Oregon to Des Moines, Iowa which today the Iowa Heart Center, a private medical group that has grown to more than 55 physicians and 300 employees, all specializing in cardiovascular disease and a highly profitable business. Dr. Phillips team pioneered techniques for emergency coronary bypass surgery for evolving heart attacks. His concept of acute intervention during a heart attack is presently the universal standard of care. He developed a funded Cardiovascular Research Laboratory at the College of Veterinary Medicine, Iowa State University. During the past 30 years his team implanted the first artificial heart in Iowa, performed the first heart transplant in central Iowa, and invented the technology for percutaneous cardiopulmonary bypass. He has been the principal investigator for numerous research projects. He retired from active medical practice in 2005. In 1997 Dr. Phillips was interviewed by the White House Search Committee for the position of Commissioner of the Food and Drug Administration. On October 7, 1998, he was invited to testify before the Full Committee on Commerce as a witness on the Implementation of the Food and Drug Administration Modernization Act of 1997. He was appointed a member of the Board of Regents of the National Library of Medicine (NLM) of the National Institutes of Health (NIH) and served from 1993-97. He was the 1997 Board Chair. In 1999 he was appointed as the full time Deputy to the Director for Research and Education at the NLM, NIH. In 2002 Dr. Phillips became a founder of and the Chief Medical Officer of Cardiovascular Hospitals of America, LLC. He retired from that position in 2001 but remains an NIH contractor.
Dr. Phillips served twice in Vietnam. He served with the 101st Airborne Division in Vietnam. Stateside he was assigned to the Department of Experimental Surgery at the Walter Reed Army Institute of Research. He returned to Vietnam with a research team to study the effects of altitude on the wounded being flown from Vietnam to the Philippines and Japan .He remained a reserve officer until his retirement as a Lieutenant Colonel. He is a life member of the 101st Airborne Association and an invited Associate Life Member of the UDT/SEAL Association. He has received numerous awards for science and community and charitable service including the International Variety Club Life Time Achievement Award. Dr. Phillips received the Governor of Iowa Science Medal for his scientific efforts and he was the National Science Advisor to the Iowa Department of Health. He presently serves as the North American Editor of the Journal of Artificial Organs, serves or served on numerous editorial, medical society and corporate boards including Dr. Michael E, DeBakey's company, Micromed, Inc., Cobe Laboratories, Inc., and Medical, Cardiovascular, Inc. Dr. Phillips is past president of the Polk County Medical Society, Iowa, past president of the Society of Cardiac Surgeons, Spain; and past president of the American Society for Artificial Internal Organs, USA. He has an active medical license in Iowa and Colorado, has approximately 300 medical publications, and has been granted 6 patents. He is a graduate of Hobart College and Tufts University School of Medicine.
PRINCETON, N.J., July 2 /PRNewswire-FirstCall/ -- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk) sees the coming long term growth opportunity positioning to provide investors more growth, profit and security of investment as it captures a larger share of the $2 trillion+ healthcare market expenditures, growing at 8.6% yearly because of the different platforms offered.
GSI brings to investors insight into GSI's business for offering long-term growth of investment in asset-backed financial transactions to the healthcare industry.
GSI is at the heart of this growth supplying 'asset-backed' financing platforms as ... (1) outright purchase of ratable (Fitch and Standard & Poor's) third party insurance receivables; (2) debt financing; and (3) equity/debt financing ... tied to the level of borrowers' cash flow generation and assets. Participation levels are $1-million and up to small, medium, large, for-profit, not-for-profit, public, private healthcare providers.
-- Driver. Providers are at a cross roads, forced by market and regulatory pressures to continually re-evaluate and make changes in ... (i) how they deliver care; (ii) in what setting; (iii) at what cost in order to just maintain the status quo. This is done by changing technology, administration, and/or delivery of patient care services ... all creating demand for capital and back office revenue management support services.
-- Continuous growth. Healthcare providers on average spend 8% on capital improvements. In the last 10 years the nationwide average age of physical plants has increased to 20 percent, add to that equipment needs to stay competitive and you've got the perfect storm of capital expenditure coming, according to Hospitals and Health Networks (H&HN).
-- GSI's uniqueness is in the details. We know the market as top management players in this industry for the last 30+ years on the team. We have developed a proprietary analysis capability to isolate the net value determination of this class of receivable and discounting, resolving or rejecting troubled receivable collections by provider errors and omissions.
-- The GSI business model has a backlog to be funded and several other 'asset-backed' projects under development. Each transaction is prepared to rating agency and investor lending standards.
-- Meeting investor expectation. The investor rewards include ... (1) Safety of investment, (2) long-term or short-term growth, (3) profitability, (4) complete in-depth oversight controls, (5) minimal risk, and (5) lockbox flow of funds managed to Contract Terms.
-- Experience and servicing history. GSI is at the heart of an industry short on cash flow and long mandatory revenue to keep competitive and meet the healthcare demands in today's and tomorrow's growing infrastructure medical care environment. Capturing a position of growth is GSI's relationship with a growing number of synergistic healthcare alliances.
The business model includes years of research and development to meet rating agency, investor and market demands in synchronization across all- sectors of the medical care continuum, supported by extensive reimbursement, a clinical, operational, accounting, contracting and legal professional expertise ... which underscores our emerging market leadership position. Ultimately, sales generation is a networking process because the common theme among medical providers is their desire to partner with a lender that has specific knowledge of their business and capability in providing creative financing solutions.
-- Gunther Slaton. Chairman; CEO and Founder of GSI Securitization Ltd. is considered an expert in the healthcare finance business in the development of business opportunities for asset-backed high profit, low risk business. He started by working with physician groups in the purchase of hospitals and moved into asset-backed financing instruments setting up a business model experienced in profiling client needs, analysis of data to budgeting and oversight controls of investments to this medical services market covering hospitals, physician groups, specialty hospitals, etal.
He works with all layers of management (1) the financial community meeting prerequisite funding; (2) processing and collection dynamics to secure optimum reimbursement for funds employed in purchasing accounts receivable; (3) security of funds protocol; (4) 24/7 reporting; and (5) operations standards.
His background as an engineer, business financial expertise, know of the healthcare industry, and its shortfalls, which have become opportunities for GSI's emerging growth has propelled GSI's business model into a public company affiliating marketing, sales, operations and reporting aspects of the business. This is management on a collaborative scale for optimum business development, cost effectiveness, and profit for the stockholders.
Beyond healthcare, Mr. Slaton was the general manager of the JELLO Division of General Foods, prior to the purchase by Kraft Foods. In other venues, he worked in the healthcare industry in different capacities in pharmaceuticals and OTC products for consumer consumption. He built, owned and operated a manufacturing and development company in partnership with USM. He graduated from New York's prestigious Stuyvesant in two years; went to the University of Wisconsin on scholarship and received a B.S. Degree in engineering; and then went to Harvard Business School. He received the Gilbreth Award Metal for high achievement in management. Mr. Slaton was born in Germany.
-- Sally Engel. Vice President Marketing and Sales of GSI Securitization Ltd. is key to business develop, processing and details of management of the business working with all phases of the financial product(s) sales, from inception to contract, and then is involved in reporting and management of oversight of the processes. A complex job covering client relationships, focused sales on individual client needs, proposals, finalizing business deal for contracting done in coordination with Mr. Slaton and all parties involved in the sale, financing and servicing of any business coming into GSI.
In addition, she is responsible for advertising and promotions of GSI and has worked extensively with research, development, demographic, market analysis, design and implementation of graphic and presentations to various targeted markets. In that environment, she is responsible for all individual sales packages with prospective client presentation and specific market product and business offerings. She also works with the public sector with GSI in public relations and stockholder relations.
She has designed, implemented and sold multiple products and services to the healthcare industry and consumer markets expanding profitable market share for Fortune 500 companies, such as FORT DODGE LABORATORIES, AMERICAN HOME PRODUCTS, CARNATION ALBERS, and BLISTEX, etal. She has been involved with GSI from its inception. She attended the University of Kansas majoring in Marketing and Business, Northwestern University business development courses in the Psychology of Marketing through Advertising, Entrepreneurship in Business, and New Trier extension courses in computer technology.
PRINCETON, N.J., July 06 /PRNewswire-FirstCall/-- GSI Securitization Ltd. (Pink Sheets: GSIEF.pk) -- The drivers behind this business are enormous as we (MediCredit & GSI) expand the 17 year established, highly profitable and growth business model to broaden the market scope for specialty Insurance Claims purchases due from the Fortune 500 insurance companies.
It is a stockholders and investors best opportunity to expand the multiples that we forecast with this business relationship. MediCredit is presently discussing with healthcare providers how to access cash flow without waiting or attempting to manage the specialty Insurance Claims that they generate. The diagnostic, clinical and rehabilitation care business will result in hundreds of millions of dollars. Each state with no fault insurance mandates insurance companies must provide for whatever services are prescribed.
The growth comes in direct proportion to funding capital availability and the market in which these funds are employed for high profitability and security of investment. Principal rated insurance companies involved in these unique business payments, include, but are not limited to, Allstate, State Farm, Liberty Mutual, Nationwide, MIC (GMAC), General Assurance, Prudential, Aetna, Geico, Hartford, Progressive, Countrywide, Encompass, Metropolitan Insurance.
Gunther Slaton, President of GSI states, 'The long-term wrap-up for expanding GSI's business in this arena is expected to compound profits many time over with the expansion of MediCredit's niche market business potential. The President and CEO of MediCredit, Seymour Spilka brings to the table a winning combination for investors capitalizing the relationship building processes with the healthcare community that takes years to develop and to obtain a following for the type business MediCredit and Seymour have created over the past 17+ years.'
It is no secret that in this industry, unlike other industries, it is not a widget sale, but rather a long term, continual credentialing type relationship that builds momentum with time. Healthcare providers want to deal with people they know and it becomes network selling. No sale is done overnight and usually, once connected you are connected long term and then get referrals as each Client is treated with special handling. We are cognizant of the patients, the physicians, the treatments, and the reimbursement protocols all of which are key elements in the services and funding instruments sold in this $2-trillion+ market.'
Gunther Slaton, President of GSI states, 'Seymour Spilka represents the paradigm for specialty insurance funding and servicing aspects of this receivable business. His resume states it all for the investors.'
Seymour Spilka, President and CEO, started MediCredit, Inc. in 1990, managing a portfolio of healthcare providers specializing in the no-fault insurance arena financing programs. Mr. Spilka set-up, coordinated, and managed the entire operations of the company in the marketing, sale, net-value determination modeling, financing, processing and collection, accounting and services of the existing and prospective Client base. The asset-backed business has continued to be highly successful and profitable as a niche market specialty business. Mr. Spilka has in excess of 40 years of in-depth experience in the insurance business, financing of receivables insurance no- fault business, processing and collection. President of General Factors Company, started as insurance premium finance company, expanded into commercial financing and leasing. In addition, he was Vice President of Western Plains Mutual Insurance Company handling specialty surplus lines insurance, Penn General Capital Corporation, subsidiary of Pennsylvania Life Insurance Company Vice President, Bankers and Shippers Insurance Company Director, subsidiary of Pennsylvania Life Insurance Company, sold to Travelers Insurance Company.
PRINCETON, N.J., July 6 /PRNewswire-FirstCall/ -- MediCredit has announced to GSI (OTC: GSIEF) that it is in the process of securing a Representative Agreement with a healthcare consultant to bring interested medical groups or individuals to GSI for funding healthcare patient accounts receivables from third-party insurance rated payors, expanding the sale, marketing and servicing arm for the joint venture group.
Gunther Slaton, President of GSI states, 'This expansion of the MediCredit business into the New England region is a bonus for the growth of 'highly profitable' business for GSI and MediCredit bottom line. We look forward to this opportunity and to future consultants who wish to capture a piece of residual highly profitable business model through sales and servicing the business they bring in.'
|
